ArticleDrugs - real world outcomes2016

First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices.

Orsolya E Lunacsek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.